NOVEL STRAIN OF BACILLUS FOR CONTROLLING PLANT DISEASE

Abstract: The present invention provides a novel Bacillus thuringiensis strain that exhibits broad antifungal and antibacterial activity. The invention also provides the use of the Bacillus thuringiensis strain or the antibiotic produced by the strain for control of a broad range of fungal and bacterial plant pathogens.

Description: NOVEL STRAIN OF BACILLUS FOR CONTROLLING PLANT DISEASE Technical Field of the Invention The present invention is in the field of biopesticides. More particularly this invention relates to the finding that a novel strain of Bacillus thuringiensis, AQ52, can inhibit a broad range of fungal and bacterial plant diseases. The invention also relates to fungicidal and bactericidal compositions comprising this novel Bacillus strain and the antibiotic produced by this strain either alone, or in combination with other chemical and biological pesticides. Background of the Invention For a number of years, it has been known that various microorganisms exhibit biological activity useful in controlling plant diseases. Although progress has been made in the field of identifying and developing biological pesticides for controlling various plant diseases of agronomic and horticultural importance, most of the pesticides in use are still synthetic compounds. Many of these chemical fungicides are classified as carcinogens by the EPA and are toxic to wildlife and other non-target species. In addition, pathogens may develop resistance to chemical pesticides (see, e.g., Schwinn et al, p. 244, ADVANCES IN PLANT PATHOLOGY: PHYTOPHTHORA INFESTANS, THE CAUSE OF LATE BLIGHT OF POTATO (Academic Press, San Diego 1991). Biological control offers an attractive alternative to synthetic chemical fungicides. Biopesticides (living organisms and the naturally produced compounds produced by these organisms) can be safer, more biodegradable, and less expensive to develop. Screening programs have identified certain Bacillus sp. (B. sp. includes B. subtilis, B. cereus, B. mycoides, B. anthracis and B. thuringiensis) strains which exhibit antifungal activity. (See, e.g., Start et al. (1990) Applied Environ. Microbiol. 60(12):4404-4412). These strains have been shown to produce zwittermicin-A and/or antibiotic B (now known as kanosamine (Milner et al. ( 1996) Appl. Environ. Microb. 62:3061-3056)), two antibiotic agents which are effective against the soil borne disease "damping-of ' caused by Phytophthora medicaginis, Phytophthora nicotianae, Phytophthora aphanidermatum or Sclerotinia minior. (See, Stabb et al. , supra). Zwittermicin-A is a water-soluble, acid-stable linear aminopolyol molecule, (see, He et al. (1994) Tetra. Lett. 35(16):2499-2502). U.S. Patent 5,049,379 to Handelsman et al describes how zwittermicin A- producing B. cereus can be used to control the below-ground seedling diseases "root rot" and "damping off in alfalfa and soybean. When the seed is coated with zwittermicin-A produced by B. cereus ATCC 53522, the pathogenic activity of the root rot fungus is inhibited. Similarly, application of spore-based formulations of certain B. cereus strains to soybean seeds or the soil surrounding the seeds has been shown to improve soybean yield at field sites. (See. Osburne et al ( 1995) Am. Phytophathol. Soc. 79(6): 551-556). Methods of applying biopesticides are well known in the art and include, for example, wettable powders, dry flowables, microencapsulation of effective agents, liquid or solid formulations and antibiotic fractions obtained from suitable cultures. (See. e.g., U.S. Patent 5.061.495 to Rossall or U.S. Patent No. 5,049,379 to Handlesman). Smith et al (1993) Plant Disease 77(2): 139-142 report that the activity of the soil-borne fungus, Pythium aphanidermatum, that causes cottony cucumber leak can be suppressed using zwittermicin-producing B. cereus strain UW85. Liefert et al (1995) J. Appl. Baderiol. 78:97-108 report the production of anti- Botrytis and anύ-Alternaria brassicicola antibiotics by two Bacillus strains. B. subtilis CL27 and B. pumilis CL45. The whole broth and cell-free filtrates were active against Botrytis and Alternaria in vitro tests and were active against Botrytis in in vivo small plants tests on Astilbe. Sholberg et al. (1995) Can. J. Microbiol 41:247-252. Swinburne et al. (1975) Trans. Brit. Mycol Soc. 65:211-217. Singh and Deferral (1984) Trns. Br. Mycol Soc. 83:487-490. and Ferreira, et al. (1991) Phytopathology 81:283-287 disclose the use of Bacillus sp. and Bacillus subtilis as biocontrol agents of fungal plant pathogens. Baker et al. (1983) Phytopathology 73:1 148-1 152 also report on an antifungal Bacillus subtilis for use on plant pathogens. Pusey et al. (1988) Plant Dis. 72:622-626, Pusey and Robins (U.S. Patent No. 5,047,239) and McKeen et al. (1986) Phytopathol 7(5:136-139 disclose control of post harvest fruit rot using B. subtilis. McKeen et al, supra, have shown that antibiotics similar to the low molecular weight iturin cyclic polypeptides contribute to this fungicidal activity of B. subtilis. Stabb et al. (1990) tested 11 Bacillus thuringiensis strains for zwittermicin production. Only one strain (BGSC4F1) tested positive for zwittermicin. This strain was weakly active against alfalfa damping off. There are no reports, however, of strains of Bacillus thuringiensis with broad fungicidal and bactericidal activity. Disclosure of the Invention A novel antibiotic-producing strain of Bacillus thuringiensis is provided that exhibits broad fungicidal and bactericidal activity. Also provided are methods of treating or protecting plants from fungal and bacterial infections comprising the step of applying an effective amount of the novel antibiotic- producing strain of Bacillus thuringiensis, AQ52. the antibiotic produced by the novel bacterial strain, or combinations thereof. In addition, at least one other antibiotic-producing microorganism or biological or chemical pesticide can be combined with the novel bacterial strain and/or antibiotic of the present invention. The novel Bacillus thuringiensis strain, AQ52, can be provided as a suspension in a whole broth culture or as an antibiotic-containing supernatant obtained from a whole broth culture of the bacterial strain. Brief Description of the Drawings: Figures 1, 2 and 3 show three gas chromatography spectra of strain AQ52 whole-cell cellular fatty acids, derivatized to methyl esters (FAMEs) using MIDI chromatography. Corresponding tabular results are found in Tables 1. 2 and 3, respectively. Modes of Carrying Out the Invention The present invention provides a novel strain of Bacillus thuringiensis which, unlike previously described Bacillus sp., exhibits broad antifungal and antibacterial activity. This novel strain is designated AQ52 and was deposited with the NRRL on August 28th, 1996 under the provisions of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purpose of Patent Procedure under Accession No. B21619. The invention also includes methods of treating or preventing fungal and bacterial diseases in plants using the novel bacterial strain or antibiotic-containing supernatants or purified antibiotic obtained from the novel bacterial strain. In addition, at least one other antibiotic-producing microorganism or biological or chemical pesticide can be combined with the novel bacterial strain and/or antibiotic of the present invention. Definitions As used herein, "biological control" is defined as control of a pathogen by the use of a second organism. Known mechanisms of biological control include enteric bacteria which control root rot by out-competing fungi for space on the surface of the root. Bacterial toxins, such as antibiotics, have been used to control pathogens. The toxin can be isolated and applied directly to the plant or the bacterial species may be administered so it produces the toxin in situ. The term "fungus" or "fungi " includes a wide variety of nucleated. sporebearing organisms which are devoid of chlorophyll. Examples of fungi include yeasts, mildews, molds, rusts, and mushrooms. The term "bacteria" includes any prokaryotic organism that does not have a distinct nucleus. "Fungicidal" means the ability of a substance to increase mortality or inhibit the growth rate of fungi. "Antibiotic" includes any substance which is able to inhibit or kill a microorganism. Antibiotics may be produced by a microorganism or by a synthetic or semisynthetic process. The term, therefore, includes a substance which inhibits or kills fungi, for example, zwittermicin-A or kanosamine. "Antifungal " includes any substance which is able to kill or inhibit the growth of fungi. The term "culturing" refers to the propagation of organisms on or in media of various kinds. "Whole broth culture" refers to a liquid culture containing both cells and media. "Supernatant" refers to the liquid broth remaining when cells grown in broth are removed by centrifugation. filtration, sedimentation or other means well known in the art. An "effective amount" is an amount sufficient to effect beneficial or desired results. An effective amount can be administered in one or more administrations. In terms of treatment and protection, an "effective amount" is that amount sufficient to palliate, ameliorate, stabilize, reverse, slow or delay the progression of fungal or bacterial disease states. We describe a novel strain of Bacillus thuringiensis that has broad antifungal and antibacterial activity. We have shown that this strain (AQ52) produces zwittermicin. This is the first reported zwittermicin-producing Bacillus thuringiensis strain to exhibit broad antifungal and antibacterial activity. In another aspect, the present invention provides a method of treating or protecting plants from fungal and bacterial infections comprising applying an effective amount of a supernatant obtained from a whole broth culture of Bacillus thuringiensis AQ52 within the present invention. The supernatant may be obtained by means well known in the art including centrifugation, filtration. sedimentation or the like. In another aspect, the invention encompasses a method of treating or protecting plants from fungal and bacterial infections comprising applying an effective amount of the novel strain of Bacillus thuringiensis as a whole broth culture. In a further aspect, the invention encompasses a method of treating or protecting plants from fungal and bacterial diseases comprising applying an effective amount of the antibiotic produced by the novel strain of Bacillus thuringiensis. In order to achieve good dispersion and adhesion of compositions within the present invention, it may be advantageous to formulate the whole broth culture, supernatant and/or the antibiotic with components that aid dispersion and adhesion. Suitable formulations will be known to those skilled in the art Compositions within the present invention can be formulated as wettable powders, granules and the like, or can be microencapsulated in a suitable medium, and the like. Examples of other formulations include, but are not limited to. soluble powders, wettable granules, dry flowables, aqueous flowables. wettable dispersible granules, emulsifiable concentrates and aqueous suspensions. Other suitable formulations will be known to those skilled in the art. All patents and publications cited herein are incorporated by reference. The following examples are provided to illustrate the invention. These examples are not to be construed as limiting. EXAMPLES Example 1 Characterization of Strain AQ52 Confirmation of Identification of AQ52 as Bacillus thuringiensis Isolates were identified based on whole-cell cellular fatty acids, derivatized to methyl esters (FAMEs) as described in Miller, L.T. (1982) J. Clin. Microbiol. 16:584-586. Gas chromatography was performed using the MIDI system (Microbial Identification System, Inc., Newark, DEL). The procedure and protocols used for growing the bacterial cultures and instrument specification are described by MIDI (Identification of bacteria by gas chromatography of cellular fatty acids. Technical Note #101. MIDI Inc., 115 Barksdale Professional Center, Newark, Delaware). Isolates were grown on TSA (BBL) plates at 28°C and cells were harvested after 24 hours. One mL of a methanolic NaOH (15% [wt/vol] NaOH in 50% [vol/vol] mefhanol) was added and cells were saponified at 100°C for 30 minutes. Esterification of fatty acids was performed using 2 mLs of 3.25 N HC1 in 46% (vol/vol) methanol at 80°C for 10 minutes. The FAMEs were extracted into 1.25 mL of 1 : 1 (vol/vol) methyl-tert-butyl ether-hexane, and the organic extract washed with 3 mL of 1.2% (wt/vol) NaOH before analysis by gas chromatography. The GC (Hewlett-Packard 5890 A) was equipped with a flame ionization detector and capillary column (Hewlett-Packard no. 19091B— 102 (Cross-linked 5% phenyl-methyl silicone; 25m X 0.22 nm ID; film thickness, 0.33 μm; phase ratio, 150) with hydrogen as the carrier gas. FAME peaks were automatically integrated by a Hewlett-Packard 3392 integrator and bacterial isolates named using the MIDI Microbial Identification Software (Sherlock TSBA Library version 3.80). The FAME profile of Xanthomonas maltophila ATCC 13637 was used as reference check for the MIDI determinations. The results of the three separate runs of the MIDI profile identified AQ52 as a Bacillus thuringiensis. The similarity index scores are as follows: run 1 : 0.180, Bacillus thuringiensis run 2: 0.177, Bacillus thuringiensis run 3 : 0.159, Bacillus thuringiensis The actual MIDI profiles of the strain are shown in Figures 1, 2, 3 and in Tables 1, 2 and 3. In addition to being characterized by FAME profiles, isolates were assessed for carbon substrate utilization using the Biolog microplate panel (Biolog, Inc., Hayward, CA) as described in Bochner (1989) Nature 339:157-158. The Biolog microplate is comprised of prefilled and dried panel wells with 95 different carbon substrates (plates are available for gram-positive and gram negative bacteria). Isolates were grown in liquid medium at 28°C and after 24 hours a washed cell suspension (0.%85 saline) was inoculated into each panel well of a GP MicroPlate (Biolog, Inc). After 24 hours at 28°C, carbon utilization reactions were assessed. Substrate utilization profiles were then compared to the Biolog Gram-Positive Data Base (release 3.50) and isolated matched to closest similar species. Biolog results give a similarity index of 0.612 positive identification as Bacillus thuringiensis. Sherlo ck Version 1.06 DATA:C96A02775A 03-OCT-96 13:44:43 ID 2902 AGRAQUEST-52 REP 1 Date of run 03-OCT-96 13 19 34 Bottle 16 SAMPLE (ARROBE) RT Area Ar/Rt Respon ECL Name % Comment 1 Comment 2 1 499 358849200 0 024 7 025 SOLVENT PEAK < min rt 1 622 738 0 022 7 403 < mm rt 3 870 1206 0 029 1 123 1 1 608 12 0 ISO 2 06 ♦ deviates 0 000 Ref 0 000 4 185 522 0 035 1 098 12 000 12 0 0 87 ♦ deviates 0 000 Ref 0 000 4 813 6324 0 028 1 063 12 612 13 0 10 22 ♦ deviates -0 000 Rel -0 001 4 905 972 0 028 1 058 12 701 13 0 ANTEISO 1 56 ♦ deviates 0 000 Ref 0 000 5 978 5574 0031 1 014 13 617 14 0 ISO 8 59 ♦ deviates -0 001 Ref -0 002 6 455 2574 0 034 0 997 14 001 14 0 3 90 ♦ deviates 0 001 Ref 0 000 7 341 12882 0 035 0 974 14 622 15 0 ISO 19 07 ♦ deviates 0 001 Ref -0 000 7 469 2292 0 035 0 970 14 71 1 15 0 ANTEISO 4 31 ♦ deviates 0 000 Ref -0 000 8 486 1320 0 039 0 948 15 386 16 1 w7c alcohol 1 90 ♦ deviates 0 000 8 634 2298 0 039 0 946 15 481 Sum In Feature 3 3 30 ♦ deviates -0 001 16 1 ISO 1/14 0 30H 8 860 6612 0 042 0 941 15 625 16 0 ISO 9 46 ♦ deviates -0 001 Ref -0 002 9 222 7080 0 040 0 935 15 856 Sum In Feature 4 10 06 ♦ deviates -0 000 16 1 w7t/15ι20H 9 448 4746 0 039 0 931 16 000 16 0 6 72 ♦ deviates 0 000 Ref -0 001 9 805 726 0 037 0 926 16 216 15 020H 1 02 ♦ deviates -0 001 10 088 2574 0 044 0 922 16 387 ISO 17 1 wlOC 3 61 ♦ deviates -0 000 10 209 1956 0 044 0 920 16 460 ISO 17 1 v,5c 2 74 ♦ deviates -0 001 10 345 546 0 040 0 918 16 542 17 1 ANTEISO l 0 76 ♦ deviates 0 001 10 490 4812 0 040 0 916 16 630 17 0 ISO 6 70 ♦ deviates 0 001 Ref 0 000 10 642 942 0 041 0 914 16 722 17 0 ANTEISO 1 31 ♦ deviates -0 000 Ref -0 001 12 605 2874 0 086 17 883 12 625 2896 0 101 17 895 > max ar/ht 12 803 1350 0063 0 889 18 000 18 0 1 82 ♦ deviates -0 000 Ref -0 001 ****** 2298 Summed Feature 3 3 30 12 0 ALDE 9 unknown 10 928 ****** 16 1 ISO 1/14 0 30H 14 0 30H/16 1 ISO ****** 7080 Summed Feature 4 10 06 15 0 ISO 20H 16 lw7t 16 1 w7t 15ι20H *ECL Solvent Ar Total Area Named Area % Named Total Amnt Nbr Rev ECL Deviation Ref ECL Shift 358849200 73710 67938 92 17 65776 13 0 001 0 001 TSBA [Rev 3 80)] Bacillus 0 180 (Bacillus cereus group) B thuringiensis 0 180 (Bacillus cereus group) B cereus 4 0 1 12 CLIN [Rev 3 80] ♦ NO MATCH ♦ RHI%-1 [Rev 1 0] ♦ NO MATCH ♦ Sherlock Version 1.06 DATA-.C96A02775A 03-OCT-96 14:10:00 ID 2903 AGRAQUEST-52 REP 2 Date of run 03-OCT-96 13 45 04 Bottle 17 SAMPLE (ARROBE) RT Area Ar/Rt Respon ECL Name % Comment 1 Comment 2 1 499 356971800 0 024 7 023 SOLVENT PEAK < mm rt 1 622 990 0 023 7 401 < min rt 3 871 1 140 0 026 1 123 1 1 608 12 0 ISO 1 86 ♦ deviates -0 000 Ref 0 001 4 188 618 0 035 1 098 12 001 12 0 0 98 ♦ deviates 0 001 Ref 0 003 4 815 6738 0 028 1 063 12 612 13 0 10 39 ♦ deviates 0 000 Ref 0 001 4 905 1008 0 029 1 058 12 700 13 0 ANTEISO 1 56 ♦ deviates -0 001 Ref 0 000 5 979 5796 0 032 1 014 13 616 14 0 ISO 8 52 ♦ deviates -0 002 Ref -0 001 6 455 2628 0 034 0 997 14 000 14 0 3 80 ♦ deviates -0 000 Rel 0 000 7 342 13062 0 034 0 974 14 621 15 0 ISO 10 44 ♦ deviates 0 000 Rel 0 001 7 471 3030 0 035 0 970 14 712 15 0 ANTEISO 4 26 ♦ deviates 0 001 Ref 0 001 7 882 576 0 041 0 961 15 000 15 0 0 80 ♦ deviates -0 000 Ref 0 000 8 487 1356 0 037 0948 15 386 16 1 w7c alcohol 1 87 ♦ deviates 0 001 8 636 2502 0 037 0 946 15 481 Sum In Feature 3 3 43 ♦ deviates -0 001 16 1 ISO 1/14 0 30H 8 862 7038 0 041 0 941 15 625 16 0 ISO 9 61 ♦ deviates -0 000 Ref -0 001 9 069 570 0 042 0938 15 758 16 0 wl lc 0 78 ♦ deviates 0 001 9 225 7362 0 039 0 935 15 857 Sun In Feature 4 9 98 ♦ deviates 0 001 16 1 w7t 15ι20H 9 450 4992 0 039 0 931 16 001 16 0 6 74 ♦ deviates 0 001 Ref 0 001 9 806 870 0 045 0 926 16 216 15 0 20E 1 17 ♦ deviates -0 001 10 088 2496 0 039 0 922 16 386 ISO 17 1 wlOc 3 34 ♦ deviates -0 001 10 210 2040 0 044 0 920 16 460 ISO 17 1 w5c 2 72 ♦ deviates -0 001 10 343 588 0 041 0 918 16 540 17 1 ANTEISO A 0 78 ♦ deviates -0 001 10 491 5226 0 038 0 916 16 630 17 0 ISO 6 94 ♦ deviates 0 001 Ref 0 001 10 644 894 0 040 0 914 16 722 17 0 ANTE1SO 1 18 ♦ deviates 0 000 Ref 0 000 12 804 654 0 045 0 889 17 999 18 0 0 84 ♦ deviates -0 001 Rel -0 001 ****** 2298 Summed Feature 3 3 43 12 0 ALDE '> unknown 10 928 * ***** 16 1 ISO 1/14 0 30H 14 0 30H/16 1 ISO I ****** 7080 Summed Feature 4 9 98 15 0 ISO 20H 16 l\v7t 16 1 v, ,7t/15ι20H *ECL Solvent Ar Total Area Named Area % Named Total Amnt Nbr Rev ECL Deviation Ref ECL Shift 356971800 71184 71184 100 00 68947 14 0 001 0 001 TSBA [Rev 3 80)] Bacillus 0 177 (Bacillus cereus group) B thuringiensis 0 177 (Bacillus cereus group) B cereus * 0 112 CLIN [Rev 3 80] ♦ NO MATCH ♦ RHI%-1 [Rev 1 0] ♦ NO MATCH ♦ Sherlock Version 1.06 DATA:C96A02775A 03-OCT-96 14:35:22 ID 2904 AGRAQUEST-52 REP 3 Date of run 03-OCT-96 14 10 20 Bottle 18 SAMPLE (ARROBE) RT Area Ar/Rt Respon ECL Name % Comment 1 Comment 2 1 500 355215000 0 028 7 023 SOLVENT PEAR < min rt 1 663 987 0 023 7 401 < min rt 3 872 1386 0 026 1 123 1 1 608 12 0 ISO 1 91 ♦ deviates -0 000 Ref 0 003 4 188 462 0029 1 098 12 001 12 0 0 62 ♦ deviates 0 000 Ref 0 003 4 816 7620 0 028 1 063 12 612 13 0 9 93 ♦ deviates 0 000 Ref 0 002 4 907 1248 0 028 1 058 12 700 13 0 ANTEISO 1 62 ♦ deviates -0 000 Ref 0 002 5 981 6954 0 032 1 014 13 616 14 0 ISO 8 64 ♦ deviates -0 001 Ref 0 001 6 457 3522 0 036 0 997 14 000 14 0 4 31 ♦ deviates -0 000 Ref 0 001 7 344 15144 0 034 0974 14 621 15 0 ISO 10 07 ♦ deviates 0 001 Ref 0 002 7 472 3828 0 035 0 970 14 712 15 0 ANTEISO 4 55 ♦ deviates 0 001 Ref 0 002 7 884 630 0 037 0 961 15 000 15 0 0 74 ♦ deviates 0 000 Ref 0 001 8 262 522 0 037 15 242 8 489 1770 0 037 0 948 15 386 16 1 w7c alcohol 2 06 ♦ deviates 0 000 8 638 2772 0 038 0946 15 482 Sum In Feature 3 3 21 ♦ deviates -0 001 16 1 ISO 1/14 030H 8 862 8508 0 041 0 941 15 624 16 0 ISO 9 82 ♦ deviates -0 002 Ref -0 001 9 071 642 0 045 0 938 15 758 16 0 wl lc 0 74 ♦ deviates 0 001 9 225 8784 0 039 0 935 15 856 Sun In Feature 4 10 07 ♦ deviates 0 000 16 1 v, 7t 15ι20H 9 451 6324 0 038 0 931 16 000 16 0 7 22 ♦ deviates 0 000 Ref 0 001 9 806 756 0 040 0 926 16 215 15 0 20E 0 86 ♦ deviates -0 002 10 091 2874 0 039 0 922 16 387 ISO 17 1 wlOc 3 25 ♦ deviates 0 000 10 212 2370 0 045 0 920 16460 ISO 17 1 2 67 ♦ deviates -0 001 10 343 654 0 040 0 918 16 539 17 1 ANTEISO A 0 74 ♦ deviates -0 002 10 493 6180 0 040 0 916 16 630 17 0 ISO 6 94 ♦ deviates 0 001 Ref 0 002 10 644 1 194 0 039 0 914 16 271 17 0 ANTEISO 1 34 ♦ deviates -O OO i Rel 0 000 12 806 648 0 038 0 889 18 000 18 0 0 71 ♦ deviates -0 000 Ref 0 001 ****** 2772 Summed Feature 3 3 21 12 0 ALDE '' unknown 10 928 * * **** 16 1 ISO 1/14 0 30H 14 0 30H/16 1 ISO l ****** 8784 Summed Feature 4 10 07 15 0 ISO 20H 16 16 1 w7t/15ι20H *ECL Solvent Ar Total Area Named Area % Named Total Amnt Nbr Rev ECL Deviation Ref ECL Shift 355215000 84792 84270 99 38 81581 14 0 001 0 002 TSBA [Rev 3 80)] Bacillus 0 159 (Bacillus cereus group) B thuringiensis 0 159 (Bacillus cereus group) B cereus * 0 107 CLIN [Rev 3 80] ♦ NO MATCH ♦ RHI%-1 [Rev 1 0] ♦ NO MATCH ♦ To determine if AQ52 produces beta-exotoxin, the following High Pressure Liquid Chromatography (HPLC) experiment was performed. A solid phase cartridge (ODS-4) was activated with 10 mL methanol and washed with 20 mL of 20 mM sodium phosphate (pH 4.0). A 2 mL sample of AQ 52 was centrifuged at 12,000 rpm for 15 minutes, passed through a 0.2 μm filter and 1 mL loaded onto the activated cartridge. After washing the cartridge with 1 mL of 20 mM sodium phosphate, the material of interest was eluted with 4 mL of 30:70 methanol/sodium phosphate into a 5 mL volumetric flask. 100 μL of 0.4M tertbutyl ammonium hydroxide was added to the flask and the volume brought up to 5 mL with water. A 200 μL sample was injected onto a C18 HPLC column (4.6 mm X 25 cm) using 45:55 methanol/tetrabutyl ammonium dihydrogen phosphate (pH 6.5) at a rate of 1 mL per minute. The UV spectrum at 254 nm was recorded for 15 minutes and compared with the UV spectrum of a known beta- exotoxin. No peaks were eluted from the AQ52 sample where beta-exotoxin normally appears. Thus, it was demonstrated that AQ52 does not produce beta- exotoxin. AQ52 Produces Zwittermicin-A Bacterial strains known to produce zwittermicin-A exhibit synergistic effects with Bacillus thuringiensis. (see, Manker et α/. WO/9409630). Therefore, to determine whether AQ52 produces zwittermicin-A, cultures of selected strains were mixed with Javelin® (B. thuringiensis) and observed for synergistic activity. More specifically, 50 mL cultures of AQ52 and known zwittermicin-producing strains AQ175 (ATC 55608) and AQ177 (ATCC 55609) were grown in TSB for three days at 29°C. The whole broth cultures were centrifuged at 4,200 g for 20 minutes. The supernatants were decanted and stored at -20°C. One mL of each supernatant was used as a stock, while one mL was diluted with 500 μL of sterile distilled water. Eight serial dilutions were then made from the diluted sample. Javelin® WG (0.0521 g) was mixed with 50 mL of distilled water to produce a 1000 μg/mL stock solution. The stock solution was then serially diluted in distilled water to give eight 0.5 mL solutions. A 50:50 mixture of the Javelin® stock solution and each supernatant stock solution were then serially diluted and then transferred to a 96-well microtiter plate. 40 μlL aliquots of each dilution were dispensed into the wells of a microtiter plate containing 200 μL/well of artificial diet. The samples were dried at room temperature and 5-10 synchronized beet army worm eggs suspended in 25 μL of a 1% agar were added to each well. The egg agar was allowed to dry, and the plates covered with perforated Mylar®. After seven days, the number of live insects in each sample well was tabulated. Results are shown in Table 4. a The "s" indicates that the living insects were extremely stunted compared to controls. nd = not done. The results show that AQ52 supernatant does not, by itself, inhibit growth of beet armyworms. However, when AQ52 supernatant is combined with B. thuringiensis, Javelin®, the synergistic effect characteristic of zwittermicin is seen as with known zwittermicin-producing strains AQ175 and AQ177. Thus, AQ52 produces a zwittermicin-like antibiotic in its supernatant. Example 2 Activity of AQ52 in in-vitro culture To determine if AQ52 is effective against the fungi, Phytophthora infestans, Pythium ultimum, Botrytis cinerea, Rhizoctonia solani, Alternaria solani, the following experiments were performed. 96-well plates (flatbottomed, 400 microliters per well, Nunc brand) were filled with an agar medium (potato dextrose agar (PDA), Difco). Phytophthora infestans cultures were grown for three days in liquid YPG-1 medium (0.4 g yeast extract, 0.1% KH 2 PO, 0.5% MgSO 4 x7H 2 O, 1.5% glucose). For the other fungi, spores were scraped from the surface of petri plates and 0.1-0.2 mLs aliquots of deionized water and spore suspension (concentration approximately 2 x 10 6 spores/mL) of pathogen were spread onto the agar. AQ52 was grown for three to five days in a cottonseed extract medium (proflo, dextrose, peptone, Trader's Protein). To test whole broth cultures, the strain was grown to approximately 9.0 x 10 8 and aliquots were taken from these cultures. Supernatant was obtained by density centrifugation of the culture at 5,200 rpm for 20 minutes. The fungal plant pathogen suspensions were pipetted onto the PDA into the 96-well plates (8 wells per pathogen). The presence or absence of fungal growth was recorded for each of 8 wells. Approximately 40 μL of AQ52 supernatant was then added to each well. A score of "1" means complete inhibition of fungal growth. A score of "4" means no inhibition of fungal growth. Results are shown in Table 5. Table 5: AQ52 Inhibition of Fungal Growth A zone inhibition test was carried out also. Fungal strains were grown and prepared as before. Petri plates were filled with PDA medium. Two 7 mm holes were made in each petri dish. A volume of 100 μL of test sample (either supernatant or whole broth) was added to each 7 mm hole. Each test was performed in duplicate. No bacterial test sample was added to the control plate. The zone of inhibition, measured in millimeters (mm) around each hole as measured 3 to 10 days. Results for the Phytophthora, Botrytis, Rhizoctonia, Alternaria, Pythium are shown in Table 5. Results are shown for supernatant (su) and whole broth (wb) in Table 6. Table 6: Zone Inhibition of Fungi by AQ52 Supernatant or Whole Broth The same experiment was repeated to test AQ52 against the fungus Trichoderma harzianum, an important pathogen of mushrooms. Trichoderma harzianum, strain T-14, was obtained from Campbell (Davis CA). A sterile number four cork borer was used to make four wells in PDA plates. AQ52 was applied to one of the four wells. Two discs of number four cork borer-sized Trichoderma mycelial plugs were added to each plate in between two wells on each side of the plate. Results were recorded 24 hours later. The size of the cleared zone between the bacterium and the mycelium was recorded. AQ52 gave a 1 mm zone from the edge of the well. To determine in vitro effectiveness of these strains against the fungi Erwinia herbicola and Monilinia frudicola. , the following experiment was conducted. Bacterial strains were cultured as described above. Monilinia frudicola cultures were grown on V-8 agar (20 g agar, 4 g CaCO 3 , 200 mL V-8 juice) in the dark at room temperature for 8 days. Spores were harvested by placing sterile distilled water on the surface of the culture plates and scraping the surface with a sterile needle to dislodge the spores. Spore concentration was adjusted to 3.3 x 10 6 spores/mL and 400 μl added to 4 mL of soft potato dextrose agar. This mixture was poured over the surface of potato dextrose agar culture places and the soft agar allowed to solidify. Erwinia herbicola was fermented overnight in half-strength TSA and 1 X 10 5 cells were mixed with soft molten agar and poured into a petri plate. Using a sterile no. 4 cork borer, 5 wells were made in each plate and 100 μL of a three day old culture of AQ52 was added to each well. Plates were incubated at room temperature in the dark and the zones of no growth of the around each well measured. Results are summarized in Table 7. Table 7: Bacterial inhibition of M. frudicola and E. herbicola These results demonstrate that AQ52 inhibited growth of M. frudicola, and also inhibited E. herbicola growth. Example 3 Antibiotic activity using whole plants The ability of AQ52 to control late blight (P. infestans) infection was tested on whole tomato plants. Tomato plants (Ace and Patio varieties) were purchased from Ace hardware. Bacterial strain AQ52 was grown to 9 X 10 8 CFU/mL in a cotton seed extract medium (peptone, dextrose, yeast, soy and proflo, Trader's Protein) for three days. P. infestans cultures were prepared as described in Example 2. Three tomato plants (1 pack) were sprayed to runoff with a whole broth culture or supernatant of AQ52, and then air-dried at approximately 70°F. Three control plants were untreated. All plants were then sprayed to runoff with a P. infestans culture at 1.55 x 10 5 CFU/mL. The plants were air-dried at 70°F, lightly misted with de-ionized water, enclosed in a clear plastic bag and incubated at approximately 16°C. The amount of late blight infestation and bacterial speck (Pseudomonas syringae) which occurred naturally on the tomatoes was recorded fifteen days after treatment. Results are shown in Table 8. Table 8 Late blight and bacterial speck infection fifteen days after treatment with AQ52 These results show that the whole broth or supernatant of AQ52 is effective against late blight and bacterial speck. Example 4 Antibiotic activity of AQ52 against B. cinerea To test the effectiveness of the antibiotic-producing bacterial strains of the present invention against B. cinerea, fresh strawberries picked the day of testing were utilized. AQ52 supernatants were obtained from strains grown in either proflo medium or in TSB. Whole broth cultures and supernatants were sprayed onto the strawberries until runoff, then allowed to air dry. B. cinerea spores were grown on potato dextrose agar in a petri plate and scraped into de-ionized water to form a liquid inoculum. The B. cinerea inoculum, measuring approximately 5.8 x 10 5 cells per mL was sprayed onto the berries until runoff, and the berries allowed to air dry. All berries were placed uncovered in an incubator at approximately 16°C. Results are shown in Table 9. Table 9 AQ52 Inhibition of 5. cinerea Whole broth cultures of AQ52 was completely effective at preventing B. cinerea infection, regardless of the medium used. Example 5 Antibiotic Activity of AQ52 Against a Spectrum of Fungal Pathogens To test the AQ52 strain against a number of fungal pathogens, AQ52 was grown in cottonseed extract media. Cells were cultured to 9.0 x 10 8 cells/mL. Replicates of three test plants and three control plants per pathogen were utilized. The test plants were each sprayed with a whole broth culture of a antibiotic - producing bacterial strain to run-off with a hand-held sprayer. When the foliage had dried, each test plant was sprayed a second time. After the second application of the bacterial strain culture has dried, the test plants and the control plants were inoculated with the appropriate fungal pathogen. Plants were incubated under conditions conducive to disease development. In addition, positive controls were utilized by testing known pesticides against appropriate fungal pathogens in the same manner as the cultures of the bacterial strains were tested. Each plant was evaluated by estimating the percent disease control using a scale from 0% control to 100% control. (0 = disease level of untreated control; 100 = plants with no visible lesions). The fungal pathogens, resulting diseases, host plant and control pesticides are presented in Table 10. The results are shown in Table 11. Table 10 Table 1 1 Rate Treatment (ppm) Pi y As | Pv 1 Un 1 Be | Sn Pr AQ52 — 0 0 98 53 100 0 87 metalaxyl 30 90 100 — — 20 — — 67 — — — — 10 47 myclobutanil 10 — — — 100 — — — 1 I — 0 — propiconazole 250 — 93 30 — 37 10 — — — — 100 100 — 5 — — — — 63 73 95 1 Disease Index — 50 80 75 30 80 80 80 (%) z ' Pi = P. infestans. As = A. solani. Pv = P. viticola. Un = U. necator. Be = B. cinerea. Sn = S. nodorum. Pr = P. recondita f.sp. tritici. (% Disease index — percent diseased tissue on the untreated, inoculated plants. AQ52 provided complete control of B. cinerea and nearly complete control of P viticola, grape downy mildew. It also has activity against rust and powdery mildew. Example 6 Activity of AQ52 versus brown rot, Monilinia frudicola on peach fruit 250 mLs cultures of AQ52 were grown in cottonseed extract medium as previously described grown for 3.5 days. Peaches were surface sterilized with 10% Clorox solution, rinsed with deionized water and air dried. Whole fermentation broths of AQ52 (7 x 10 " CFU/mLs) were sprayed with a hand held sprayer on two peaches until runoff (approximately 50 mLs per two peaches). The peaches were allowed to air dry. Monilinia spores were scraped from a petri plate and suspended in deionized water to at 1.09 x 10 5 cells per mL. The peaches were sprayed with the spore suspension until runoff and allowed to air dry. Two peaches were untreated and two peaches were sprayed with Monilinia, but with no treatments. The peaches were placed in a polypropylene container in an incubator in the dark at 18°C. Four and six days later the amount of brown rot was recorded. The following results were recorded: Table 12 AQ52 Inhibition of ' M. frudicola The results show that AQ52 suppressed Monilinia brown rot on peaches compared to the untreated controls and Monilinia only peaches. The treatments at 4 days had only one peach with brown rot the size of the lesions was much smaller than the untreated and Monilinia controls. At six days, the peaches were all heavily infected with brown rot, but the size of the lesions in the AQ52 treatment was still smaller than in the untreated or Monilinia only controls. Having now fully described this invention, it will be appreciated by those skilled in the art that the same can be performed within a wide range of equivalent parameters, concentrations and conditions without departing from the spirit and scope of the invention and without undue experimentation. While this invention has been described in connection with specific embodiments thereof, it will be understood that it is capable of further modifications. This application is intended to cover any variations, uses or adaptations of the invention following, in general, the principles of the invention and including such departures from the present disclosure as come within known or customary practice within the art to which the invention pertains and as may be applied to the essential features hereinbefore set forth as follows the scope of the appended claims.

Claims: CLAIMS What is claimed is: 1. An isolated, pure culture of Bacillus thuringiensis strain AQ52, NRRL Acession No. B21619. 2. An antibiotic produced by the Bacillus thuringiensis strain of claim 1 that exhibits broad spectrum antimicrobial activity against fungi and bacteria. 3. A method for protecting or treating plants and fruit from fungal and bacterial infections comprising applying an effective amount of the Bacillus thuringiensis strain of claim 1. 4. A method of claim 3 wherein the infections are caused by at least one of microorganism of the group consisting of Phytophthora infestans, Botrytis cinerea, Uncinula necator, Puccinia recondita, Plasmopara viticola, Erwinia herbicola, Monilinia frudicola Alternaria solani, Pseudomonas syringae and Trichoderma harzianum. 5. The method of 3, wherein the Bacillus thuringiensis strain AQ52 is applied as a whole broth culture. 6. The method of claim 3, wherein the Bacillus thuringiensis strain AQ52 is applied as a supernatant. 7. The method of claim 3, wherein the Bacillus thuringiensis strain AQ52 is applied as a combination of a whole broth culture and a supernatant. 8. The method of claim 3, wherein the Bacillus thuringiensis strain is applied as wettable powders, granules, flowables. or microencapsulations 9. The method of claim 6. wherein the Bacillus thuringiensis strain is applied as wettable powders, granules, flowables, or microencapsulations. 10. The method of claim 3, further comprising at least one chemical or biological pesticide. 1 1. The method of claim 6. further comprising at least one chemical or biological pesticide.

Inventors: BROADWELL ANDREW, CHILCOTT CHRIS N, HEINS SHERRY D, JIMENEZ DESMOND R, MANKER DENISE C, MARRONE PAMELA GAIL, WIGLEY PETER, BROADWELL, ANDREW, CHILCOTT, CHRIS, N., HEINS, SHERRY, D., JIMENEZ, DESMOND, R., MANKER, DENISE, C., MARRONE, PAMELA, GAIL, WIGLEY, PETER
Applicants: AGRAQUEST INC, BIODISCOVERY NEW ZEALAND LTD, BROADWELL ANDREW, CHILCOTT CHRIS N, HEINS SHERRY D, JIMENEZ DESMOND R, MANKER DENISE C, MARRONE PAMELA GAIL, WIGLEY PETER, AGRAQUEST, INC., BIODISCOVERY NEW ZEALAND, LTD., BROADWELL, ANDREW, CHILCOTT, CHRIS, N., HEINS, SHERRY, D., JIMENEZ, DESMOND, R., MANKER, DENISE, C., MARRONE, PAMELA, GAIL, WIGLEY, PETER
Application year: 1997
Main classification: A01N63
IPC codes: A01N63, C07G11, C12N1, C12R1